Navigation Links
Pixantrone Combination Therapy for First-line Treatment of,Aggressive Non-Hodgkin's Lymphoma Results in Reduction in Severe,Toxicities Including Heart Damage When Compared to,Doxorubicin-based Therapy

o clinical studies of pixantrone in aggressive NHL patients, RAPID and a phase III single agent trial, known as EXTEND. The EXTEND trial explores the role of single-agent treatment as a salvage regimen in patients with relapsed aggressive NHL who have failed at least two prior treatment regimens. Patients are randomized to receive either pixantrone or another single-agent drug of the physician's choice currently used for the treatment of this patient population. An interim look for the EXTEND trial is planned for later this year.

The Company is awaiting feedback from the FDA on the design of a new phase III trial of pixantrone for patients with indolent NHL. The trial, PIX303, will examine the complete remission rates and time to disease progression for the combination regimen of fludarabine, pixantrone and rituximab (FP-R) compared to the combination of fludarabine and rituximab (F-R) in the treatment of patients who have received at least one prior treatment for NHL. The trial is expected to enroll 300 patients.

About Pixantrone

Pixantrone is an investigational agent under development for the potential treatment of various hematological malignancies, solid tumors and immunological disorders. It was developed to improve the activity and safety of the anthracycline family of anti-cancer agents. Anthracyclines have been shown to be very active clinically in a number of tumor types. However, they are usually associated with cumulative heart damage that prevents them from being used in a large proportion of patients. Pixantrone has been designed to reduce the potential for these severe cardiotoxicities, as well as to potentially increase activity and permit simplified administration compared to the currently marketed anthracyclines.

About Cell Therapeutics, Inc.

Headquartered in Seattle, CTI is a biopharmaceutical company committed to developing an integrated portfolio of oncology products aimed at making cancer more treatable. For ad
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
2. Publication on Pixantrone Preclinical Studies Demonstrates Reduced Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and Mitoxantrone
3. Pixantrone Granted Fast Track Designation by FDA for Relapsed Indolent NHL Patients
4. New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV
5. Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib Combination Studies
6. An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes
7. Late Breaking Data Released at ADA Showed that the Investigational Use of Januvia and Metformin as Initial Combination Therapy Provided Significant Glucose Lowering Efficacy over 54 Weeks in Patients with Type 2 Diabetes
8. Poniard Pharmaceuticals Announces Promising Data From Interim Safety Analysis of Phase 1 Combination Trials of Picoplatin in Colorectal and Prostate Cancers
9. Peregrine Pharmaceuticals Reports Positive Top-Line Results in Bavituximab Combination Therapy Trial in Advanced Cancer Patients
10. Intarcia Therapeutics Announces Presentation of Final Results From a Phase 2 Combination Study for the Treatment of Hepatitis C at the Digestive Disease Week Conference
11. Data Presented at ASH Demonstrate Nebivolol Lowers Blood Pressure as Long-Term Monotherapy and in Combination Therapy
Post Your Comments:
(Date:8/28/2014)... 28, 2014 Reportlinker.com announces ... is available in its catalogue: ... Broadened Diagnostic Criteria and Growing Adult ... Patent Expirations ... to 2020 - Broadened Diagnostic Criteria ...
(Date:8/28/2014)... --  RapidForce , an innovative muscle support and pain ... professional tennis player John Isner . Currently the ... competitions to help with knee support. He is wearing ... US Open Tennis Championships. Fifteen times ... a revolutionary hybrid of a brace and kinesiology tape. ...
(Date:8/28/2014)... , Aug. 28, 2014 The Leukemia ... a partnership to advance an experimental cancer vaccine ... an asymptomatic stage of myeloma. The ... through which LLS forges collaborations with biotechnology companies ... OncoPep is developing a vaccine, PVX-410, ...
Breaking Medicine Technology:ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations 2ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations 3ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations 4ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations 5ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations 6ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations 7ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations 8America's top-ranked tennis player John Isner Joins Forces with RAPIDFORCE Physio Hybrid Shapes 2America's top-ranked tennis player John Isner Joins Forces with RAPIDFORCE Physio Hybrid Shapes 3America's top-ranked tennis player John Isner Joins Forces with RAPIDFORCE Physio Hybrid Shapes 4The Leukemia & Lymphoma Society Provides Equity Financing to OncoPep to Support Clinical Trial for Myeloma Vaccine 2
... Jan. 25, 2011 Mylan Inc. (Nasdaq: MYL ... agreement with Pfizer Inc. resolving litigation related to Caduet® Tablets, ... mg, 5 mg/20 mg, 5 mg/40 mg, 5 mg/80 mg, ... 10 mg/80 mg, known generically as Amlodipine Besylate/Atorvastatin Calcium Tablets. ...
... 2011 eCareSoft recently launched eCS Inpatient EHR V1.2 ... for small and medium hospitals. eCS,s uniqueness is the ... management systems into a single web-based software solution. The ... reduced costs and simplified deployment. "eCS is ...
Cached Medicine Technology:Mylan Announces Caduet® Settlement Agreement 2eCareSoft Launches Comprehensive EHR for Small & Medium Hospitals 2
(Date:8/28/2014)... 2014 Parker Waichman LLP, a national ... fighting to ensure that the heroes of 9/11 are ... to WTC victims who developed 9/11-related cancer was reaffirmed ... Office (GAO). According to a statement issued by ... is entitled “World Trade Center Health Program: Approach Used ...
(Date:8/28/2014)... Watertown, MA (PRWEB) August 28, 2014 ... , is delighted to present its new Kids’ Share, which ... Share will encourage kids (and their parents) to get into ... their very own vegetable share. Each week the Kids’ Share ... fabulous veggies, shares will include activities for kids, recipes from ...
(Date:8/28/2014)... August 28, 2014 Clarity PSO ... been re-certified as a federal Patient Safety Organization (PSO) ... Agency for Healthcare Research and Quality (AHRQ). Clarity PSO ... expertise and services following the true intentions of the ... , ”We are proud and eager to continue our ...
(Date:8/28/2014)... 2014 (HealthDay News) -- Having greater amounts of yellow ... see distant objects in hazy conditions, a new study ... researchers simulated hazy conditions in order to test the ... pigment (also called macular pigment) in their eyes. ... which represents accumulations of the nutrients lutein and zeaxanthin, ...
(Date:8/28/2014)... August 28, 2014 GreenRushReview.com, a ... recently launched a “Video” section located at ... information on various cannabis companies in video format. ... an assortment of news clips, interviews, and other ... A portion of the videos can also be ...
Breaking Medicine News(10 mins):Health News:GAO Report Reaffirms Decision to Add Cancers to List of Illnesses Covered under the Zadroga Act, Parker Waichman LLP Comments 2Health News:GAO Report Reaffirms Decision to Add Cancers to List of Illnesses Covered under the Zadroga Act, Parker Waichman LLP Comments 3Health News:Kids Don't Have to Share Their Vegetables, Thanks to Siena Farms, ChopChop Magazine & Chef Ana Sortun 2Health News:Kids Don't Have to Share Their Vegetables, Thanks to Siena Farms, ChopChop Magazine & Chef Ana Sortun 3Health News:Kids Don't Have to Share Their Vegetables, Thanks to Siena Farms, ChopChop Magazine & Chef Ana Sortun 4Health News:Clarity PSO Re-lists as a Patient Safety Organization and Continues to Advance Patient Safety 2Health News:Clarity PSO Re-lists as a Patient Safety Organization and Continues to Advance Patient Safety 3Health News:Eye Pigment May Help Vision in Hazy Conditions 2Health News:Emerging Cannabis Industry Website GreenRushReview.com Adds a Featured Video Section to Cover Marijuana Business Sector News 2Health News:Emerging Cannabis Industry Website GreenRushReview.com Adds a Featured Video Section to Cover Marijuana Business Sector News 3
... perpetual inventory management system designed to meet unique ... and GAINESVILLE, Fla., Jan. 29 Omnicell, Inc. ... of system solutions to acute healthcare facilities, and ... Specialty supply chain management systems (formerly known as ...
... 29 The Shambhala Meditation Center of Los Angeles will ... master of Quigong - an ancient practice of physical fitness, ... to balance and retain youthfulness in the body. The ... & 8th at the Center for the Arts in Eagle ...
... Mettler-Toledo,International Inc. (NYSE: MTD ) today announced ... results on Thursday, February 5, 2009,at 5:00 p.m. Eastern Time. ... on the Company,s website. A replay of the webcast ... METTLER TOLEDO is a leading global supplier of precision ...
... drug-free approach to common childhood ailments, complement pediatricians.ARLINGTON, ... parents are adding pediatric chiropractic care as an ... data indicates that the percentage of chiropractic patients ... least 8.5 percent since 1991, says the American ...
... between two important protein kinase signaling pathways that are ... in the January 30th issue of the journal ... multiple types of cancer. , The protein kinase LKB1 ... pathway couples energy metabolism with cell growth, proliferation and ...
... The commonwealth,s latest statewide survey on uninsured ... health insurance coverage -- an increase from a similar ... "Overall, the study showed that increases in uninsured numbers ... certain ethnic groups and most geographic areas," Ario said. ...
Cached Medicine News:Health News:Shands HealthCare Increases Operational Efficiency in Surgical Suites With Omnicell Supply Systems 2Health News:Shands HealthCare Increases Operational Efficiency in Surgical Suites With Omnicell Supply Systems 3Health News:World-renowned Instructor of the Healing Practice of Qigong to Teach in Los Angeles Mar. 7 & 8 2Health News:Increasing Number of Children Receive Pediatric Chiropractic Care 2Health News:Oncogene inhibits tumor suppressor to promote cancer: Study links B-RAF and LKB1 2Health News:More Pennsylvanians Are Without Insurance and Health Care, Insurance Department Survey Shows 2Health News:More Pennsylvanians Are Without Insurance and Health Care, Insurance Department Survey Shows 3Health News:More Pennsylvanians Are Without Insurance and Health Care, Insurance Department Survey Shows 4
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: